Korean College of Helicobacter and Upper Gastrointestinal Research

Today 2020.08.12 D-DAY -26

Scientific Program

Program Details

  >  Scientific Program  >  Program Details

Program is subject to change.

8:00- Registration
9:00- Opening remark: Jae Gyu Kim (President of the KCHUGR)
9:00-10:20 Scientific session 1: Updates on the treatment of H. pylori infection
Chairs: Soo-Heon Park (The Catholic University of Korea, Korea), Beom Jin Kim (Chung-Ang University, Korea)
9:00-9:20 Prolonging treatment duration vs. adding bismuth: Role of bismuth in eradication Sun-Young Lee
(Konkuk University, Korea)
9:20-9:40 High dose PPI vs. P-CAB: Role of acid inhibition in eradication of H. pylori Takahisa Furuta
(Hamamatsu University, Japan)
9:40-10:00 Culture-based vs. empirical salvage therapy for H. pylori eradication Jyh-Ming Liou
(National Taiwan University, Taiwan)
10:00-10:20 Antibiotics vs. probiotics for eradication: Impact of eradication on gut microbiota Nayoung Kim
(Seoul National University, Korea)
10:20-10:40 Break
10:40-11:40 Symposium: Management of GI disorders in Asia
Chairs: Jun Haeng Lee (Sungkyunkwan University, Korea), Sung Woo Jung (Korea University, Korea)
10:40-10:55 New insights on management of dyspepsia, gastric ulcer and gastritis Ratha-korn Vilaichone
(Thammasat University, Thailand )
10:55-11:10 Rebamipide and small bowel bleeding Than Than Aye
(University of Medicine 2 Yangon, Myanmar)
11:10-11:25 Treatment of H. pylori resistant patient Miguel Edgardo M. Fores
(Makati Medical Center, Philippines )
11:25-11:40 Follow-up testing after treatment of H. pylori infection Chan Gyoo Kim
(National Cancer Center, Korea)
11:40-12:20 Special Lecture
Chair: Sang Woo Lee (Korea University, Korea)
11:40-12:20 Publishing in gastroenterology: An editor’s perspective Yong Chan Lee
(Yonsei University, Korea)
12:20-13:20 General Assembly

Luncheon Symposium 1
Chairs: Jong-Jae Park (Korea University, Korea), Dae Young Cheung (The Catholic University of Korea, Korea)
12:20 - 13:20 Therapeutic advance in acid-related disease: The present and the future Kee Don Choi
(University of Ulsan, Korea)
13:20-15:00 Scientific session 2: Asian forum: H. pylori infection and malignant diseases
Chairs: Jae Gyu Kim (Chung-Ang University, Korea), Gwang Ha Kim (Pusan National University, Korea)
13:20-13:30 Gastic cancer and H. pylori in Thailand Varocha Mahachai
(Chulalongkorn University, Thailand )
13:30-13:40 H. pylori infection and gastric cancer in Myanmar Than Than Aye
(University of Medicine 2 Yangon, Myanmar)
13:40-13:50 H. pylori infection and malignant diseases in Philippines Ruter Maralit
(University of the Philippines, Philippines)
13:50-14:00 Status of H. pylori infection and related diseases in Vietnam Vu Van Khien
(108 Central Hospital, Vietnam)
14:00-14:10 H. pylori infection in Malaysia Alex Hwong Ruey Leow
(Pantai Hospital Kulala Lumpur, Malaysia)
14:10-14:20 H. pylori infection and malignant diseases in Mongolia Sarantuya Gidaagaya
(Intermed Hospital, Mongolia)
14:20-14:30 H. pylori infection and gastric cancer in Singapore Tiing Leong Ang
(Changi General Hospital, Singapore)
14:30-14:40 H. pylori infection and malignant diseases in Indonesia Marcellus Simadibrata
(Universitas Indonesia, Indonesia)
14:40-15:00 Discussion
15:00-15:20 Break
15:20-16:20 Plenary session
Chairs: Sang-Yong Seol (Inje University, Korea), Sam-Ryoung Jee (Inje University, Korea)
15:20-15:35 Effect of Helicobacter pylori reinfection on metachronous cancer risk after endoscopic submucosal dissection for early gastric cancer Jae Ok Park
(National Cancer Center, Korea)
15:35-15:50 Isolation of Helicobacter pylori using leftover tissue from rapid urease test kit Eun Jeong Gong
(University of Ulsan, Korea)
15:50-16:05 HERES (highly expressed lncRNA in esophageal squamous cell carcinoma) Epigenetically Regulates WNT-signal pathway in Esophageal Squamous Cell Carcinoma Sang Kil Lee
(Yonsei University, Korea)
16:05-16:20 Results from the pilot study of the multicentre randomised trial of H. pylori eradication and pepsinogen testing for prevention of gastric cancer mortality (the GISTAR Pilot study) Jin Young Park
(International Agency for Research on Cancer, France)
16:20-17:20 Scientific session 3: Identification and management of high-risk populations in gastric cancer
Chairs: Ki-Baik Hahm (CHA University, Korea), Seong Woo Jeon (Kyungpook National University, Korea)
16:20-16:40 Transcriptome based molecular subtyping for precision medicine in gastric cancer Jae-Ho Cheong
(Yonsei University, Korea)
16:40-17:00 Epigenetic risk startification of healthy people after H. pylori eradication Toshikazu Ushijima
(National Cancer Center, Japan)
17:00-17:20 Genetic predisposition and alterations Hark Kyun Kim
(National Cancer Center, Korea)